Breaking News Instant updates and real-time market news.

PACB

Pacific Biosciences

$3.26

-0.09 (-2.69%)

04:55
06/13/17
06/13
04:55
06/13/17
04:55

Pacific Biosciences management to meet with Stephens

Meetings to be held in Milwaukee/Chicago on June 12 and in Chicago on June 13 hosted by Stephens.

  • 13

    Jun

  • 13

    Jun

PACB Pacific Biosciences
$3.26

-0.09 (-2.69%)

12/01/16
WBLR
12/01/16
NO CHANGE
WBLR
Celgene, Zoetis among top healthcare picks at William Blair
William Blair analysts named their top health care picks for 2017, identifying Evolent Health (EVH) as their top HC Services and HC IT pick, Zoetis (ZTS) as their top dental and animal health pick,and Pacific Biosciences (PACB) as their top diagnostic services and life sciences choice, The firm identified ARIAD (ARIA), Celgene (CELG) and SAGE Therapeutics (SAGE) as their top biotech choices. It named Edwards Lifesciences (EW), Nevro (NVRO), and K2M Group (KTWO) as its favorite med tech picks.
12/15/16
CANT
12/15/16
NO CHANGE
Target $15
CANT
Overweight
Cantor says Roche deal termination significant negative for Pacific Biosciences
Cantor Fitzgerald analyst Bryan Brokmeier said Roche's (RHHBY) termination of its collaboration agreement with Pacific Biosciences is a "significant negative" for the latter, as he was forecasting Roche-generated revenues of $14.3M in 2017 and $27.5M in 2018. Pacific Bio should not lose all of that revenue, since it will now be able to sell into the clinical market or partner with another company, but that will require further investments, said Brokmeier, who has an Overweight rating and $15 price target on the stock.
12/15/16
PIPR
12/15/16
NO CHANGE
Target $6
PIPR
Neutral
Pacific Biosciences price target lowered to $6 from $10 at Piper Jaffray
Piper Jaffray analyst William Quirk lowered his price target for Pacific Biosciences (PACB) to $6 from $10 after Roche (RHHBY) terminated its Sequel system contract with the company. Pacific Biosciences believes Roche's decision stems from a change in the sequencing market dynamics, the analyst notes, adding that Roche said "somewhat vaguely" that Sequel can no longer meet a list of requirements the company established. Additionally, Quirk believes the mid-point of Pacific Biosciences' 2017 guidance may be difficult to reach, and reiterates a Neutral rating on the shares.
12/15/16
CANT
12/15/16
NO CHANGE
Target $8
CANT
Overweight
Pacific Biosciences a 'viable takeout target,' says Cantor
Cantor analyst Bryan Brokmeier says Pacific Biosciences' (PACB) shares are oversold after the company announced that Roche (RHHBY) has terminated their IVD-distribution agreement, whereby Roche had exclusive distribution rights of the Sequel into the clinical market. While the analyst acknowledges Roche's termination of the agreement is a clear long-term strategic negative, he says it is not nearly as much as the stock selloff is implying and notes that Pacific Biosciences is now positioned to sell into the clinical sequencing market directly or through other partners. Moreover, Brokmeier believes Pacific Biosciences is now "effectively a viable takeout target" for other companies, with Agilent (A), Bio-Techne (TECH), Illumina (ILMN), PerkinElmer (PKI), Thermo Fisher (TMO), and Roche among potential acquirers. He reiterated an Overweight rating on Pacific Biosciences' stock, but lowered his price target on the shares to $8 from $15.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

15:17
08/17/17
08/17
15:17
08/17/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
08/17/17
08/17
15:16
08/17/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDS

Dillard's

$55.18

-0.75 (-1.34%)

15:10
08/17/17
08/17
15:10
08/17/17
15:10
Options
Dillards draws defensive option flow as shares fall »

Dillards draws defensive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:05
08/17/17
08/17
15:05
08/17/17
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

EPD

Enterprise Products

$25.07

-0.1 (-0.40%)

15:00
08/17/17
08/17
15:00
08/17/17
15:00
Options
Put buyers in Energy Products Partners »

Put buyers in Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$36.84

-2.11 (-5.42%)

14:58
08/17/17
08/17
14:58
08/17/17
14:58
Recommendations
L Brands analyst commentary  »

L Brands not in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

NUE

Nucor

$54.75

-1.98 (-3.49%)

14:58
08/17/17
08/17
14:58
08/17/17
14:58
Syndicate
Breaking Syndicate news story on Nucor »

Nucor files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$29.21

0.03 (0.10%)

, TSRO

Tesaro

$112.99

-1.01 (-0.89%)

14:50
08/17/17
08/17
14:50
08/17/17
14:50
Recommendations
AstraZeneca, Tesaro, Clovis analyst commentary  »

Lynparza labeling could…

AZN

AstraZeneca

$29.21

0.03 (0.10%)

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

CLVS

Clovis

$71.77

-0.11 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

GOOG

Alphabet

$926.96

4.74 (0.51%)

, GOOGL

Alphabet Class A

$944.27

6.19 (0.66%)

14:50
08/17/17
08/17
14:50
08/17/17
14:50
Periodicals
Google piloting data-friendly Search app in Indonesia, TechCrunch reports »

Google is pilot testing a…

GOOG

Alphabet

$926.96

4.74 (0.51%)

GOOGL

Alphabet Class A

$944.27

6.19 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

AMAT

Applied Materials

$44.46

0.58 (1.32%)

14:49
08/17/17
08/17
14:49
08/17/17
14:49
Options
Applied Materials options imply 6.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

AZN

AstraZeneca

$29.17

-0.015 (-0.05%)

, CLVS

Clovis

$71.77

-0.11 (-0.15%)

14:44
08/17/17
08/17
14:44
08/17/17
14:44
Hot Stocks
Feuerstein says Lynparza approval shows FDA sees no differences in PARPs »

STAT's Adam…

AZN

AstraZeneca

$29.17

-0.015 (-0.05%)

CLVS

Clovis

$71.77

-0.11 (-0.15%)

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

FSM

Fortuna Silver Mines

$4.49

-0.01 (-0.22%)

14:30
08/17/17
08/17
14:30
08/17/17
14:30
Options
6.5K Fortuna Silver Mines Aug - Sep 4 call spreads for 9c »

6.5K Fortuna Silver Mines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:30
08/17/17
08/17
14:30
08/17/17
14:30
General news
NY Fed's Survey of Primary Dealers showed expectations for December hike »

NY Fed's Survey of…

PCLN

Priceline

$1,855.72

-5.115 (-0.27%)

14:26
08/17/17
08/17
14:26
08/17/17
14:26
Recommendations
Priceline analyst commentary  »

Priceline recent pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAH

Platform Specialty Products

$12.21

-0.345 (-2.75%)

14:25
08/17/17
08/17
14:25
08/17/17
14:25
Options
Platform Specialty Products call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
08/17/17
08/17
14:25
08/17/17
14:25
General news
Canada CPI Preview »

Canada CPI Preview:…

TLSYY

Telstra

$17.11

0.585 (3.54%)

14:23
08/17/17
08/17
14:23
08/17/17
14:23
Downgrade
Telstra rating change  »

Telstra downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$57.49

-0.785 (-1.35%)

, XLI

Industrial Select Sector SPDR

$67.77

-0.84 (-1.22%)

14:23
08/17/17
08/17
14:23
08/17/17
14:23
Technical Analysis
Technical View: S&P 500 breaks another support layer »

The S&P 500 (SPX) is…

XLK

Technology Select Sector SPDR

$57.49

-0.785 (-1.35%)

XLI

Industrial Select Sector SPDR

$67.77

-0.84 (-1.22%)

XLY

Consumer Discretionary Sector SPDR

$89.23

-0.9 (-1.00%)

XLF

Financial Select Sector

$24.78

-0.26 (-1.04%)

SPY

SPDR S&P 500 ETF Trust

$244.48

-2.465 (-1.00%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$111.10

-0.48 (-0.43%)

14:18
08/17/17
08/17
14:18
08/17/17
14:18
Hot Stocks
ADP says Pershing presentation contains nothing not already analyzed »

ADP issued a statement in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

$NSD

NASDAQ Market Internals

14:17
08/17/17
08/17
14:17
08/17/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$30.29

-0.01 (-0.03%)

14:16
08/17/17
08/17
14:16
08/17/17
14:16
Hot Stocks
Goodyear Tire names Christopher Helsel Chief Technology Officer »

The Goodyear Tire &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
08/17/17
08/17
14:16
08/17/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USB

U.S. Bancorp

$52.02

-0.83 (-1.57%)

14:15
08/17/17
08/17
14:15
08/17/17
14:15
Options
US Bancorp put volume heavy and directionally bearish »

Bearish flow noted in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 18

    Oct

  • 17

    Jan

14:10
08/17/17
08/17
14:10
08/17/17
14:10
General news
Fed dove Kashkari said Fed would consider the debt ceiling »

Fed dove Kashkari said…

AVGO

Broadcom

$253.42

-0.27 (-0.11%)

, CSCO

Cisco

$32.34

0.25 (0.78%)

14:08
08/17/17
08/17
14:08
08/17/17
14:08
Hot Stocks
FTC approves final order on Broadcom's acquisition of Brocade »

Following a public…

AVGO

Broadcom

$253.42

-0.27 (-0.11%)

CSCO

Cisco

$32.34

0.25 (0.78%)

BRCD

Brocade

$12.24

0.03 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 24

    Aug

  • 06

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.